Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Department of Critical Care Medicine and Neuroscience Institute, TriHealth, Cincinnati, OH, United States.
Handb Clin Neurol. 2020;172:51-61. doi: 10.1016/B978-0-444-64240-0.00003-9.
Trauma is the leading cause of nonobstetric maternal mortality and affects up to 8% of all pregnancies. Pregnant patients with traumatic brain injury (TBI) are an especially vulnerable population, and their management is complex, with multiple special considerations that must be taken into account. These include but are not limited to alterations in maternal physiology that occur with pregnancy, potential teratogenicity of pharmacologic therapies and diagnostic studies using ionizing radiation, need for fetal monitoring, Rh immunization status, placental abruption, and preterm labor. Despite these challenges, evidence regarding management of the pregnant patient with a TBI is lacking, limited to only case reports/series and retrospective analyses. Despite this uncertainty, expert opinion on management of these patients seems to be that, overall, the standard therapies for management of TBI are safe and effective in pregnancy, with a few notable exceptions described in this chapter. Significant work is needed to continue to develop best-practice and evidence-based guidelines for the management of TBI pregnancy.
创伤是导致非产科孕产妇死亡的主要原因,影响了多达 8%的所有妊娠。创伤性脑损伤 (TBI) 的孕妇是一个特别脆弱的群体,她们的管理非常复杂,需要考虑多种特殊因素。这些因素包括但不限于妊娠时母体生理学的变化、药物治疗和放射性诊断研究的潜在致畸性、胎儿监测的需要、Rh 免疫状态、胎盘早剥和早产。尽管存在这些挑战,但关于 TBI 孕妇管理的证据很少,仅限于病例报告/系列和回顾性分析。尽管存在这种不确定性,但专家对这些患者的管理意见似乎是,总的来说,TBI 管理的标准治疗在怀孕期间是安全有效的,只有少数在本章中描述的明显例外。需要做大量工作来继续制定 TBI 妊娠管理的最佳实践和循证指南。